A proposal for quality standards for measuring medication adherence in research

scientific article

A proposal for quality standards for measuring medication adherence in research is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10461-012-0172-7
P932PMC publication ID3434290
P698PubMed publication ID22407465
P5875ResearchGate publication ID221693455

P50authorK Rivet AmicoQ58238816
Carol BovaQ59144251
P2093author name stringAnn Bartley Williams
Julie A Womack
P2860cites workStatistical methods for assessing agreement between two methods of clinical measurementQ26778461
Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in BotswanaQ28221847
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcomeQ30670830
Adjusting and censoring electronic monitoring device data. Implications for study outcomesQ31081014
Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patientsQ33320339
Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherenceQ33393729
An examination of the psychometric properties of the Antiretroviral General Adherence Scale (AGAS) in two samples of HIV-infected individualsQ33679085
Attaining higher goals in HIV treatment: the central importance of adherenceQ33765198
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.Q33834254
Practical and conceptual challenges in measuring antiretroviral adherenceQ33835857
Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical managementQ33851716
Adherence: a necessity for successful HIV combination therapy.Q33961694
Adherence in chronic diseaseQ33986619
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trialsQ34120588
Real-time adherence monitoring for HIV antiretroviral therapyQ34284065
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapyQ34381830
Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoringQ34699180
An analysis of electronically monitored adherence to antiretroviral medicationsQ35161647
Methods for evaluation of medication adherence and persistence using automated databasesQ36412470
Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephoneQ36416650
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measuresQ36547005
Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty?Q36951006
Use of electronic monitoring in clinical nursing researchQ36973993
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoringQ37217490
Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in BotswanaQ37340992
Importance of dose timing to achieving undetectable viral loadsQ37379594
Relationship of prospective memory to neuropsychological function and antiretroviral adherenceQ37393648
Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issuesQ37395005
Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memoryQ37419533
The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological statesQ38473145
Adherence to antiretroviral therapy in a home-based AIDS care programme in rural UgandaQ38878886
Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited settingQ38881891
Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinicQ39575431
Adherence to protease inhibitor therapy and outcomes in patients with HIV infectionQ39605935
Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and deathQ39702981
The elusive gold standard. Future perspectives for HIV adherence assessment and interventionQ40265692
The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment GroupQ40806729
The assessment of refill compliance using pharmacy records: methods, validity, and applicationsQ41361915
HIV therapeutics: confronting adherenceQ41632789
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACQ41752733
A practical method to calibrate self-reported adherence to antiretroviral therapyQ43512109
Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.Q43612758
Optimal recall period and response task for self-reported HIV medication adherenceQ43753135
Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in MozambiqueQ43811493
Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variablesQ44193921
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort StudyQ44524787
Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective studyQ45108750
Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trialQ46212340
Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavirQ46494163
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scaleQ46572937
Electronic monitoring device event modelling on an individual-subject basis using adaptive Poisson regressionQ47188648
Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations.Q51509651
A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.Q51930660
Bayes and health care research.Q51979450
A comparison study of multiple measures of adherence to HIV protease inhibitors.Q52062736
Adherence, compliance, and HAART.Q53966618
Diagnostic Value of Different Adherence Measures Using Electronic Monitoring and Virologic Failure as Reference StandardsQ56778249
Use of Electronic Monitoring Induces a 40-Day Intervention Effect in HIV PatientsQ56778338
Differential impact of adherence on long-term treatment response among naive HIV-infected individualsQ57259643
Validity of Self-Reported Adherence Among Injection Drug UsersQ57259665
A randomized comparison of two instruments for measuring self-reported antiretroviral adherenceQ58106370
Adherence to Antiretroviral Medication Among HIV-Positive Patients in ThailandQ58275507
Self-Reported Adherence to Antiretroviral Therapy for HIV-1 Infection and Virologic Treatment ResponseQ58478514
Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic settingQ59647423
Public Health Implications of Antiretroviral Therapy and HIV Drug ResistanceQ59700719
Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patientsQ74239445
Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoringQ74493692
Accuracy of a provincial prescription database for assessing medication adherence in heart failure patientsQ80781080
A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIVQ80967260
Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income womenQ82310699
Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparatorsQ83040872
Using different calculations of pharmacy refill adherence to predict virological failure among HIV-infected patientsQ84968345
Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable respondingQ85017689
P433issue1
P304page(s)284-297
P577publication date2013-01-01
P1433published inAIDS and BehaviorQ15752229
P1476titleA proposal for quality standards for measuring medication adherence in research
P478volume17

Reverse relations

cites work (P2860)
Q36943508A New Frontier: Integrating Behavioral and Digital Technology to Promote Health Behavior
Q37486409A Self-Reported Adherence Measure to Screen for Elevated HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy
Q99418164A data-driven typology of asthma medication adherence using cluster analysis
Q35558205Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials
Q57136315Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy
Q35538913Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study
Q47550476Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis.
Q37242342Adherence to immunosuppressive therapy following liver transplantation: an integrative review
Q38854507Alcohol Interactive Toxicity Beliefs and ART Non-adherence Among HIV-Infected Current Drinkers in Mbarara, Uganda
Q38434065Assessing adherence to multiple medications and in daily life among patients with multimorbidity
Q38156105Assessing medication adherence: options to consider
Q38944299Association between self-reported adherence and HIV viral load suppression among older children and adolescents
Q59340209Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China
Q38063174Cognitive interviewing for cross-cultural adaptation of pediatric antiretroviral therapy adherence measurement items
Q91274143Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure
Q33713856Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial
Q37736861Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
Q36356513Computation of adherence to medication and visualization of medication histories in R with AdhereR: Towards transparent and reproducible use of electronic healthcare data.
Q47272447Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review
Q36030946Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence
Q35408032Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with men
Q40335852Correlation of Adherence by Pill Count, Self-report, MEMS and Plasma Drug Levels to Treatment Response Among Women Receiving ARV Therapy for PMTCT in Kenya
Q36710299Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice
Q35780443Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm
Q35956767Desirability and feasibility of wireless electronic monitoring of medications in clinical trials
Q39544268Development of an algorithm for analysing the electronic measurement of medication adherence in routine HIV care
Q34085477Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysis
Q38966648ESPACOMP Medication Adherence Reporting Guidelines (EMERGE): a reactive-Delphi study protocol
Q38191840Electronic measurement of medication adherence
Q40239354Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.
Q64136527Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China
Q35916350Factors associated with non-adherence of adults infected with HIV on antiretroviral therapy in a referral hospital in Douala
Q57476286Factors related to Adherence to Opioids in Black Patients with Cancer Pain
Q33450648Feasibility and Acceptability of a Smartphone App for Daily Reports of Substance Use and Antiretroviral Therapy Adherence among HIV-Infected Adults
Q89415217Fecal Coliform Bacterial Detection to Assess Enema Adherence in HIV Prevention Clinical Studies
Q90682884Food insecurity is associated with lower levels of antiretroviral drug concentrations in hair among a cohort of women living with HIV in the United States
Q48198008Health Behavior Change in Older Adults: Testing the Health Action Process Approach at the Inter- and Intraindividual Level.
Q38994456Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems
Q47551904Higher Art Adherence is Associated with Lower Systemic Inflammation in Treatment-Naïve Ugandans Who Achieve Virologic Suppression
Q37639074Housing Stability and Medication Adherence among HIV-Positive Individuals in Antiretroviral Therapy: A Meta-Analysis of Observational Studies in the United States.
Q28078707How to Screen for Non-Adherence to Antihypertensive Therapy
Q27318276Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.
Q57297481Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration
Q92073006Implementation of Medication Event Reminder Monitors among patients diagnosed with drug susceptible tuberculosis in rural Viet Nam: A qualitative study
Q33787619Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations
Q94397641Measures of antiretroviral adherence for detecting viral non‐suppression in people living with HIV
Q88884687Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China
Q47954113Measuring medication adherence in asthma: Development of a novel self-report tool.
Q37031305Medication beliefs and structural barriers to treatment adherence among people living with HIV infection
Q38197715Medicine non-adherence in kidney transplantation.
Q38062882Methodological lessons from clinical trials and the future of microbicide research
Q34337475Microbicide clinical trial adherence: insights for introduction
Q47589574Mindfulness instruction for HIV-infected youth: a randomized controlled trial
Q55210131Monitoring self-reported adherence to antiretroviral therapy in public HIV care facilities in Brazil: A national cross-sectional study.
Q52323543Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling.
Q27313352Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study
Q92727139Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study
Q99548133Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States
Q52324625Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.
Q52642676Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model.
Q93383889Predictive validity of the Sidorkiewicz instrument in Spanish: Assessing individual drug adherence in psychiatric patients
Q45740586Prescribing in prison: minimizing psychotropic drug diversion in correctional practice
Q93135267Prevalence and determinants of adherence to antiretroviral treatment among HIV patients on first-line regimen: a cross-sectional study in Dakar, Senegal
Q38903094Proposal of Standardization to Assess Adherence With Medication Records: Methodology Matters.
Q55005002Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques.
Q47121506Reaching the end of the line: Operational issues with implementing phone-based unannounced pill counts in resource-limited settings
Q41021229Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection.
Q26775742Self-report measures of medication adherence behavior: recommendations on optimal use
Q36994992Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study
Q33798685State of the science of adherence in pre-exposure prophylaxis and microbicide trials
Q33948938Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection
Q38918721The INCATM (Inhaler Compliance AssessmentTM): A comparison with established measures of adherence.
Q41227413The Information and Motivation and Behavioral Skills Model of ART Adherence among HIV-Positive Adults in Mexico.
Q33690506The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood
Q90074393Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa
Q64081064Triggered Escalating Real-Time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing Antiretroviral Therapy: Protocol for a Triggered Escalating Real-Time Adherence Intervention
Q33913873Validity of behavioral measures as proxies for HIV-related outcomes